How to deal with Behcet’s disease in daily practice
- 3 May 2010
- journal article
- research article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 13 (2) , 105-116
Abstract
Introduction: Behcet’s Disease (BD) is classified as a vasculitis, and progresses via attacks and remissions. BD is mainly seen around the Silk Road. The picture varies in different reports. For clinical descriptions, the data from the international cohort of patients (27 countries), will be used.Clinical manifestations: Mucous membrane manifestations were oral aphthosis seen in 98.1%, and genital aphthosis in 76.9% of patients. Skin manifestations were seen in 71.9% (pseudofolliculitis in 53.6% and erythema nodosum in 33.6%). Ocular manifestations were seen in 53.7% (anterior uveitis 38.8%, posterior uveitis 36.9%, retinal vasculitis 23.5%). Joint manifestations were seen in 50.5% (arthralgia, monoarthritis, oligo/polyarthritis, ankylosing spondylitis). Neurological manifestations were seen in 15.5% of patients (central 11.5%, peripheral 4.4%). Gastrointestinal manifestations were seen in 6.3% of patients. Vascular involvement was seen in 18.2% of patients and arterial involvement in 3% (thrombosis, aneurysm, pulse weakness). Deep vein thrombosis was seen in 8%, large vein thrombosis in 6.5%, and superficial phlebitis in 5.8%. Orchitis and epididymitis were seen in 7.2%. Pathergy test was positive in 49.3% and HLA‐B51 in 49.1% of patients.Diagnosis: Diagnosis is based on clinical manifestations. The International Criteria for Behcet’s Disease (ICBD) may be helpful.Treatment: The first line treatment is colchicine (1 mg daily) for mucocutaneous manifestations, non‐steroidal anti‐inflammatory drugs for joint manifestations, anticoagulation for vascular thrombosis, and cytotoxic drugs for ocular and brain manifestations. If incomplete response or resistance occurs, therapeutic escalation is worthwhile.Conclusion: Behcet’s disease is a systemic disease characterized by mucocutaneous, ocular, vascular and neurologic manifestations, progressing by attacks and remissions.Keywords
This publication has 45 references indexed in Scilit:
- Epidemiology and clinical characteristics of behçet's disease in the US: A population‐based studyArthritis Care & Research, 2009
- Nailfold capillaroscopy in Behçet’s disease, analysis of 128 patientsClinical Rheumatology, 2009
- Infliximab Treatment for Ocular and Extraocular Manifestations of Behçet's DiseaseJapanese Journal of Ophthalmology, 2007
- Clinical manifestations of Behcet's disease in Chinese patientsInternational Journal of Rheumatic Diseases, 2006
- Repeated Intravitreal Triamcinolone Injections in Behçet Disease That Is Resistant to Conventional Therapy: One-year ResultsAmerican Journal of Ophthalmology, 2006
- Behçet's disease in Lebanon: clinical profile, severity and two-decade comparisonClinical Rheumatology, 2005
- Multiple aneurysms in an Iranian patient with neuro‐Behcet's diseaseInternational Journal of Rheumatic Diseases, 2005
- A Controlled Trial of Azathioprine in Behçet's SyndromeNew England Journal of Medicine, 1990
- Treatment of Behcet's disease with dapsoneClinical Rheumatology, 1989
- Treatment of Behçet's disease with thalidomideClinical Rheumatology, 1986